Immunovant, Inc. (IMVT)
NASDAQ·Healthcare·Biotechnology
$27.39
-4.30%
Mkt Cap $6.00B
Analyst Ratings
Buy
3
Hold
3
Sell
0
Price Target (9 analysts)
$45.50
Range $41.00 – $50.00
Implied Upside
+66.1%
Consensus $45.50 vs current $27.39
NASDAQ·Healthcare·Biotechnology
$27.39
-4.30%
Mkt Cap $6.00B
Buy
3
Hold
3
Sell
0
Price Target (9 analysts)
$45.50
Range $41.00 – $50.00
+66.1%
Consensus $45.50 vs current $27.39